Patents Assigned to Mater Medical Research Institute
  • Publication number: 20160015786
    Abstract: Disclosed is the use of a HIF-? potentiating agent and a mobilizer of hematopoietic stem cells and/or progenitor cells in methods and compositions for mobilizing hematopoietic stem cell and progenitor cells from the bone marrow into the peripheral blood. The compositions and methods are particularly useful for stem cell transplantation and for treating or preventing immune deficiencies.
    Type: Application
    Filed: November 4, 2013
    Publication date: January 21, 2016
    Applicant: MATER MEDICAL RESEARCH INSTITUTE LIMITED
    Inventors: Jean-Pierre Jose Rene Levesque, Ingrid Gabriele WINKLER
  • Publication number: 20110002881
    Abstract: This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present invention is particular useful for prophylaxis and/or treatment of hematopoietic disorders including neutropenia, agranulocytosis, anemia and thrombocytopenia in individuals receiving or proposed to receive treatments that target rapidly dividing cells or that disrupt the cell cycle or cell division.
    Type: Application
    Filed: November 7, 2008
    Publication date: January 6, 2011
    Applicant: Mater Medical Research Institute
    Inventors: Jean-Pierre Levesque, Ingrid Winkler